Expression of secretory leukocyte protease inhibitor and elafin in human fallopian tube and in an in-vitro model of Chlamydia trachomatis infection

Human Reproduction

Volumn 24, Issue 3, 2009, Pages 679-686

  King, Anne E ^a   Wheelhouse, Nick ^b   Cameron, Sharon ^c   McDonald, Sarah E ^a   Lee, Kai Fai ^d   Entrican, Gary ^b   Critchley, Hilary O D ^a   Horne, Andrew W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MOREDUN RESEARCH INSTITUTE   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chlamydia trachomatis; Ectopic pregnancy; Elafin; Fallopian tube; Secretory leukocyte protease inhibitor

Indexed keywords

ELAFIN; MESSENGER RNA; PROTEINASE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ADULT; ARTICLE; BIOPSY; CELL LINE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; ECTOPIC PREGNANCY; ENZYME ACTIVITY; EPITHELIUM; FEMALE; GENITAL SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOCALIZATION; IN VITRO STUDY; INNATE IMMUNITY; LUTEAL PHASE; MENSTRUAL CYCLE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; UTERINE TUBE; UTERINE TUBE MUCOSA; WOUND HEALING;

CHLAMYDIA TRACHOMATIS;

EID: 61449140184     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/den452     Document Type: Article

References (43)

1. Ashcroft GS, Lei K, Jin W et al. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med 2000;6:1147-1153.
2. Bakken IJ. Chlamydia trachomatis and ectopic pregnancy: recent epidemiological findings. Curr Opin Infect Dis 2008;21:77-82.
3. Dalgetty DM, Sallenave JM, Critchley HO et al. Altered secretory leukocyte protease inhibitor expression in the uterine decidua of tubal compared with intrauterine pregnancy. Hum Reprod 2008; 23:1485-1490.
4. den Hartog JE, Ouburg S, Land JA et al. Do host genetic traits in the bacterial sensing system play a role in the development of Chlamydia trachomatis-associated tubal pathology in subfertile women? BMC Infect Dis 2006;6:122.
5. Draper DL, Landers DV, Krohn MA et al. Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am J Obstet Gynecol 2000;183:1243-1248.
6. Faro S. Chlamydia trachomatis: female pelvic infection. Am J Obstet Gynecol 1991;164:1767-1770.
7. Farquhar CM. Ectopic pregnancy. Lancet 2005;366:583-591.
8. Fichorova RN, Anderson DJ. Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod 1999;60:508-514.
9. Franken C, Meijer CJ, Dijkman JH. Tissue distribution of antileukoprotease and lysozyme in humans. J Histochem Cytochem 1989;37:493-498.
10. Hiemstra PS, Maassen RJ, Stolk J et al. Antibacterial activity of antileukoprotease. Infect. Immun. 1996;64:4520-4524.
11. Horne AW, Stock SJ, King AE. Innate immunity and disorders of the female reproductive tract. Reproduction 2008;135:739-749.
12. Huang HY, Chan SH, Wu CH et al. Interleukin-1 system messenger ribonucleic acid and protein expression in human Fallopian tube may be associated with ectopic pregnancy. Fertil Steril 2005;84: 1484-1492.
13. Jabbour HN, Kelly RW, Fraser HM et al. Endocrine regulation of menstruation. Endocr Rev 2006;27:17-46.
14. Ji YF, Chen LY, Xu KH et al. Locally elevated leukemia inhibitory factor in the inflamed Fallopian tube resembles that found in tubal pregnancy. Fertil Steril 2008; (epub ahead of print).
15. Jin FY, Nathan C, Radzioch D et al. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 1997;88:417-426.
16. King AE, Critchley HOD, Kelly RW. Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role. Mol. Hum. Reprod. 2000; 6:191-196.
17. King AE, Critchley HO, Kelly RW. Innate immune defences in the human endometrium. Reprod Biol Endocrinol 2003a;1:116.
18. King AE, Critchley HOD, Sallenave JM et al. Elafin in human endometrium: An anti-protease and anti-microbial molecule expressed during menstruation. J. Clin. Endocrinol. Metab 2003b;88:4426-4431.
19. King AE, Morgan K, Sallenave JM et al. Differential regulation of secretory leukocyte protease inhibitor and elafin by progesterone. Biochem Biophys Res Commun 2003c;310:594-599.
20. Kutluay L, Vicdan K, Turan C et al. Tubal histopathology in ectopic pregnancies. Eur J Obstet Gynecol Reprod Biol 1994;57:91-94.
21. Lee YL, Lee KF, Xu JS et al. Establishment and characterization of an immortalized human oviductal cell line. Mol Reprod Dev 2001; 59:400-409.
22. Lee SK, Lee SS, Hirose S et al. Elafin expression in human fetal and adult submandibular glands. Histochem Cell Biol 2002;117:423- 430.
23. Lemus JF. Ectopic pregnancy: an update. Curr Opin Obstet Gynecol 2000; 12:369-375.
24. Moriyama A, Shimoya K, Ogata I et al. Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle. Mol Hum Reprod 1999;5:656-661.
25. Narvekar N, Lakha F, Critchley HO et al. Changes in vaginal morphology, steroid receptor and natural antimicrobial content following treatment with low-dose mifepristone. Contraception 2007;75:271- 280.
26. Ota Y, Shimoya K, Zhang Q et al. The expression of secretory leukocyte protease inhibitor (SLPI) in the Fallopian tube: SLPI protects the acrosome reaction of sperm from inhibitory effects of elastase. Hum Reprod 2002a;17:2517-2522.
27. Ota Y, Shimoya K, Zhang Q et al. The expression of secretory leukocyte protease inhibitor (SLPI) in the Fallopian tube: SLPI protects the acrosome reaction of sperm from inhibitory effects of elastase. Hum. Reprod. 2002b;17:2517-2522.
28. Pfundt R, van Ruissen F, van Vlijmen-Willems IM et al. Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia. J. Clin. Invest. 1996;98:1389-1399.
29. Sallenave JM. Antimicrobial activity of antiproteinases. Biochem. Soc. Trans. 2002;30:111-115.
30. Sallenave JM, Ryle AP. Purification and characterization of elastase-specific inhibitor. Sequence homology with mucus proteinase inhibitor. Biol. Chem. Hoppe Seyler 1991;372:13-21.
31. Sallenave JM, Marsden MD, Ryle AP. Isolation of elafin and elastase-specific inhibitor (ESI) from bronchial secretions. Evidence of sequence homology and immunological cross-reactivity. Biol Chem Hoppe Seyler 1992;373: 27-33.
32. Sallenave JM, Shulmann J, Crossley J et al. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am. J. Respir. Cell Mol. Biol. 1994;11:733-741.
33. Sallenave JM, Cunningham GA, James RM et al. Regulation of pulmonary and systemic bacterial lipopolysaccharide responses in transgenic mice expressing human elafin. Infect Immun 2003;71:3766-3774.
34. Simpson AJ, Maxwell AI, Govan JR et al. Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens. FEBS Lett. 1999;452:309-313.
35. Simpson AJ, Wallace WA, Marsden ME et al. Adenoviral augmentation of elafin protects the lung against acute injury mediated by activated neutrophils and bacterial infection. J Immunol 2001;167: 1778-1786.
36. Thompson RC, Ohlsson K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc. Natl. Acad. Sci. U.S.A. 1986; 83:6692-6696.
37. Tomee JF, Koeter GH, Hiemstra PS et al. Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option? Thorax 1998;53:114-116.
38. Valore EV, Wiley DJ, Ganz T. Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis. Infect Immun 2006;74:5693- 5702.
39. Wheelhouse N, Wattegedera S, Fleming D et al. Chlamydia trachomatis and Chlamydophila abortus induce the expression of secretory leukocyte protease inhibitor in cells of the human female reproductive tract. Microbiol Immunol 2008;52:465-468.
40. Wiedow O, Schroder JM, Gregory H et al. Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J. Biol. Chem. 1990;265:14791-14795.
41. Wiedow O, Luademann J, Utecht B. Elafin is a potent inhibitor of proteinase 3. Biochem. Biophys. Res. Commun. 1991;174:6-10.
42. Wiedow O, Harder J, Bartels J et al. Antileukoprotease in human skin: an antibiotic peptide constitutively produced by keratinocytes. Biochem Biophys Res Commun 1998;248:904-909.
43. Williams SE, Brown TI, Roghanian A et al. SLPI and elafin: one glove, many fingers. Clin Sci (Lond) 2006;110:21-35.